Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 11696 composition records across product categories including Home maintenance, Personal care, Pesticides.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 · limited confidence.
Prevalence of PROPYLPARABEN in our catalog (epa_cpdat).
Products
11,696
Brands
6
Typical roles
Catalog
Co-occurrence
Ingredients that frequently appear alongside PROPYLPARABEN in the catalog.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 11696 composition records across product categories including Home maintenance, Personal care, Pesticides. EPA CPDat classifies this chemical for functional uses including Preservative, Fragrance, Food preservative.
US
FDA
Route: AURICULAR (OTIC); Dosage form: DROPS; Potency: NA
US
FDA
Miswak
Dabur
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: NA
US
FDA
Route: BUCCAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 1 mg
US
FDA
Route: DENTAL; Dosage form: PASTE, DENTIFRICE; Potency: NA
US
FDA
Route: INFILTRATION; Dosage form: INJECTION; Potency: 0.35 mg
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: 0.03 %w/v
US
FDA
Route: INTRALESIONAL; Dosage form: INJECTION; Potency: 0.02 %w/v
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 6 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 0.4 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 5 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Potency: 0.02 %w/v
US
FDA
Route: INTRAMUSCULAR; Dosage form: SOLUTION; Potency: 0.02 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 6 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 0.8 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 5 mg
US
FDA
Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: 0.02 %w/v
US
FDA
Route: OPHTHALMIC; Dosage form: DROPS; Potency: 0.01 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: OINTMENT; Potency: 0.01 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.02 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 0.01 %w/v
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.01 %w/w
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 1 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 0.22 mg
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Potency: 2.5 mg/5ml
US
FDA
Route: ORAL; Dosage form: LIQUID; Maximum daily exposure: 2 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 13 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 8 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION, CONCENTRATE; Potency: 0.2 mg/1ml
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 64 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 4 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 40 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 0.14 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 0.8 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 0.12 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 0.04 mg
US
FDA
Route: PARENTERAL; Dosage form: INJECTION; Maximum daily exposure: 2 mg
US
FDA
Route: RECTAL; Dosage form: SOLUTION; Potency: 0.02 %w/v
US
FDA
Route: RECTAL; Dosage form: SUSPENSION; Maximum daily exposure: 271 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Potency: 0.01 %w/w
US
FDA
Route: SOFT TISSUE; Dosage form: INJECTION; Potency: 0.02 %w/v
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 2 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION; Potency: 0.02 %w/v
US
FDA
Route: SUBCUTANEOUS; Dosage form: SUSPENSION; Potency: 0.02 %w/v
US
FDA
Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 0.04 %w/w
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 6 mg
US
FDA
Route: TOPICAL; Dosage form: CREAM, AUGMENTED; Maximum daily exposure: 2 mg
US
FDA
Route: TOPICAL; Dosage form: EMULSION; Potency: 0.06 %w/w
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 1 mg
US
FDA
Route: TOPICAL; Dosage form: JELLY; Maximum daily exposure: 180 mg
US
FDA
Route: TOPICAL; Dosage form: LIQUID; Potency: 0.1 %w/w
US
FDA
Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 140 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Potency: 0.2 %w/w
US
FDA
Route: TOPICAL; Dosage form: SHAMPOO; Potency: 0.03 %w/w
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 24 mg
US
FDA
Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 21 mg
US
FDA
Route: VAGINAL; Dosage form: CREAM; Maximum daily exposure: 3 mg
US
FDA
Route: VAGINAL; Dosage form: GEL; Maximum daily exposure: 2 mg
US
FDA
FDA NDC lists this ingredient in 4 active drug products and 12 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.